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APPLICATION OF FT-IR SPECTROSCOPY  
FOR DETERMINATION OF CLARITHROMYCIN IN PHARMACEUTICALS 
Method for the qualitative and quantitative assessment of clarithromycin – macrolide antibiotic – in 
pharmaceutical formulations was developed by using Fourier-transform infrared (FT-IR) transmission 
spectroscopy for quality control. The calibration model was developed based on simple Beer's law us-
ing the FT-IR carbonyl region (C=O) from 1,750 to 1,675 cm−1. Statistical analysis of the results was 
developed by using TQ Analyst program and based on the least square method. The good coefficient of 
determination was achieved R2 = 0.9973. Recovery was achieved from 98 to 106%. The method based 
on the FT-IR spectroscopy for the quantitative analysis of clarithromycin in pharmaceutical formula-
tions is a fast and promising technique. 
Introduction. Clarithromycin is antibiotic, se-
misynthetic macrolide consisting of 14-membered 
lactone ring (Fig.1). Clarithromycin has antibiotic 
spectrum, it participates against respiratory pathogens 
and it is one of the main means of prevention and 
treatment (in combination with other chemotherapeu-
tic agents) of mycobacteriosis in HIV infection [1]. 
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Fig. 1 Chemical structure of  clarithromycin 
For qualitative and quantitative control of clar-
ithromycin medicines IR spectroscopy and HPLC 
are used, respectively [2]. Various electrochemical 
and other methods are also developed. Analysis 
with these methods requires the use of expensive 
solvents, complex sample preparation and time  
 
consuming. FT-IR spectroscopy is the primary 
method of identifying a drug substance included in 
all pharmacopoeia. IR spectra may be obtained not 
only for pure substances, but also for medicaments. 
At the same time excipients included in the drug 
should not suppress the spectrum of the active sub-
stance [2]. In the modern pharmaceutical analysis 
of drugs it is important to develop reliable express 
methods in order to identify, to carry out quantifi-
cation of the active substance and its uniform dis-
tribution. Therefore, the development of fast meth-
ods of qualitative and quantitative analysis on the 
basis of FT-IR spectroscopy is an urgent task [3]. 
Main part. The aim of the work is to explore 
the possibility of using FTIR spectroscopy not only 
for quality but also for quantitative analysis in 
pharmaceutical formulations. The objects of study 
were commercial preparations “Clarithromycin” 
produced by JV limited company Farmland Bela-
rus. According to the Core Data Sheet each tablet 
contains 250 mg of clarithromycin and the follow-
ing excipients: corn starch, microcrystalline cellu-
lose, sodium glycolate, talc purified, povidone K-
30, magnesium stearate.  
Identification of clarithromycin in medicine 
was carried out by the characteristic absorption 
bands. A spectrum of substances of clarithromycin 
was used as comparison spectrum. 
 
Fig. 2. IR spectra of clarithromycin tablet (1) and a standard sample of clarithromycin (2)
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Investigations were carried out using FT-IR of 
Nexus 670 Thermo Nicolet in the transmission 
mode in the range of 4,000–400 cm–1 averaging 
32 scans at a resolution of 4 cm–1. Samples were 
prepared as KBr tablets of 13 mm in diameter 
weighing 250 mg. Background spectrum was reg-
istered before recording the spectrum of each sam-
ple which is then subtracted. From a comparison of 
the tablet spectra and the sample of clarithromycin 
spectra it can be concluded that the absorption 
spectrum of clarithromycin in tablet is not sup-
pressed by auxiliaries. Therefore, this method is 
suitable for the identification of clarithromycin in 
medicines. 
Calibration curve was obtained with nine stan-
dard with clarithromycin content from 0.2 to 1 mg. 
Quantitation was carried out by peak area in the 
region of carbonyl absorption bands: 1.750–
1.675 cm–1 (Fig. 3). 
 
 
Fig. 3. Region of absorbance carbonyl groups  
of clarithromycin standards 
 
The studies have shown a good dependence of 
the peak area of the concentration of clarithromy-
cin. In this area there is not a superposition of  
 
peaks of test components and excipients (Fig.4). 
Data processing was performed with TQ Analyst, 
using Beer's law, technique of least squares.  
The equation of the calibration curve is y = 15.0·x, 
the coefficient of linear regression, R2 = 0.9973 
(Fig. 5). 
The applicability of the developed technique of 
quantitative analysis of clarithromycin was deter-
mined on the commercial product containing 
clarithromycin, 250 mg (tablet weights approxi-
mately 500 mg). According to the research, the con-
tent of clarithromycin in the drug was (244.51 ±  
± 6.92) mg. Admissible deviation of weight of act-
ing substances in the tablet with a dosage of 10 to 
1,000 mg must not exceed ± 7.5%, or in this case, 
± 18.25 mg. This example confirms the possibility 
of using FT-IR spectroscopy for the quantitative 
determination of clarithromycin in medicines. 
To eliminate the interference of absorption of 
carbonyl groups of clarithromycin and some 
groups of additives as well as water at 1,630 cm–1, 
which could affect the quantitation method “en-
tered:found” was applied. 5, 10 and 15 mg of the 
standard sample of clarithromycin was added to 
finely ground tablet (50 mg) (28.94 mg clarithro-
mycin). Measurements were performed three times 
at each of the points and determine the coefficient 
of the extraction. 
Calculation of the recovery efficiency was car-
ried out by the formula (1) [4, 5]. 
100,C AZ
B
−
= ⋅  
where Z – the recovery efficiency, %; С – found 
content of clarithromycin in 50 mg tablet, after the 
addition of the standard, mg; А – content of clar-
ithromycin in 50 mg tablet before the addition of 
the standard, mg; В – amount of injected standard 
sample of clarithromycin, mg. 
 
 
Fig. 4. Infrared spectra of clarithromycin and excipients
Wavenumbers, сm–1
A
bs
or
ba
nc
e,
 u
n.
. 
1,750 2,000 
 
 
Wavenumbers, сm–1 3,000 2,000 
 
 
 
 Clarithromycin 
 
Hydroxypropylmethylcellulose 
 
Magnesium stearate 
 
Microcrystalline cellulose 
 
Talcum 
 
Sodium lauryl sulfate 
A
bs
or
ba
nc
e,
 u
n.
 
Biotechnology 
 
187
 
Fig. 5. Calibration of clarithromycin standarts 
 
The results of this study are given in the table. 
The results of content analysis of clarithromycin  
by analysis of spiked samples 
Initial content, 
mg 
entered, 
mg 
found, 
mg 
Recovery  
efficiency, % 
28.9 5 34.2 106.0 
28.9 10 38.7 98.0 
28.9 15 44.0 100.6 
Acceptable recovery efficiency is 90–108% [3]. 
The obtained results satisfy these requirements, 
which means that there is no overlay of the absorp-
tion bands of clarithromycin and excipients and 
they have no effect on the signal intensity, which 
confirm the possibility to control the amount of 
clarithromycin in medicine with given additive 
substances. The equation of the calibration curve 
by the method of least squares had the form 
y = 0.93 · x + 0.59. Coefficient of linear regression 
was R2 = 0.9954.  
Conclusion. Research conducted have shown 
that the method of Fourier-transform infrared spec-
troscopy can be used not only for qualitative but  
 
also for the quantitative analysis of clarithromycin 
in pharmaceutical formulations for the evaluation 
of the quality index as “uniformity of content”. 
This will reduce the cost and time of analysis com-
pared with traditionally used method HPLC. 
Moreover, the application of FTIR spectroscopy 
method does not require dissolution of the drug 
and the extraction of the active substance, and it 
can also be used for the simultaneous determina-
tion of additives, including the insoluble compo-
nents contained in pharmaceuticals.  
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